1 Min Read
Jan 9 (Reuters) - Galmed Pharmaceuticals Ltd
* Galmed pharmaceuticals ltd- completed recruitment for its phase iib arrest study; results from study are anticipated to be announced in q2 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.